Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
glyphosate
Pharma
Bayer expects weaker 2023 thanks to lower glyphosate sales
Just as the calls for a business separation grow louder at Bayer, the company’s weedkiller performance is bolstering the argument.
Angus Liu
Jul 25, 2023 10:56am
Judge rejects Bayer's 'unreasonable' $2B Roundup settlement
May 27, 2021 11:00am
Bayer's pharma business falls short as Roundup liability grows
Nov 3, 2020 11:29am
Bayer extends CEO tenure by 3 years
Sep 11, 2020 11:33am
Bayer's Eylea resilient amid COVID-19, but China price cut hurts
Aug 4, 2020 12:07pm
Bayer reworks $1.25B part of Roundup settlement
Jul 10, 2020 11:42am